Skip to main content
. 2022 Mar 21;35:10225. doi: 10.3389/ti.2021.10225

TABLE 2.

Tacrolimus TDD, trough levels and trough:TDD by period (mITT population).

TDD, mean (SD), mg LCPT (N = 200) IR-Tac/PR-Tac (N = 201) IR-Tac (N = 86) PR-Tac (N = 115)
 Week 3 to Month 6 5.17 (2.97) 6.28 (3.56) 5.54 (2.91) 6.81 (3.88)
 Overall 5.85 (3.08) 6.96 (3.65) 6.33 (3.24) 7.43 (3.88)
 Week 1 10.96 (3.08) 11.72 (3.16) 11.34 (3.02) 12.01 (3.26)
 Week 2 8.75 (4.01) 9.54 (4.55) 8.76 (3.94) 10.10 (4.87)
 Week 3 8.07 (4.20) 9.20 (4.86) 8.17 (3.78) 9.93 (5.40)
 Week 4 7.41 (4.02) 8.57 (4.64) 7.47 (3.66) 9.36 (5.11)
 Months 1–3 5.80 (3.27) 7.00 (3.80) 6.23 (3.37) 7.56 (4.01)
 Months 3–6 4.45 (2.87) 5.44 (3.23) 4.82 (2.74) 5.91 (3.50)
Trough Levels, Mean (SD), ng/ml
 Week 3 to Month 6 9.40 (1.72) 9.00 (1.67) 8.86 (1.51) 9.11 (1.78)
 Overall 10.69 (2.58) 10.11 (2.12) 10.60 (2.46) 9.76 (1.76)
 Week 1 13.96 (5.91) 13.07 (5.05) 14.59 (5.22) 11.94 (4.63)
 Week 2 10.65 (3.67) 9.66 (3.60) 10.24 (3.54) 9.24 (3.60)
 Week 3 10.70 (4.42) 9.91 (3.38) 10.45 (3.11) 9.52 (3.52)
 Week 4 10.47 (3.52) 9.96 (3.04) 9.76 (2.54) 10.12 (3.38)
 Months 1–3 9.69 (2.22) 9.36 (2.42) 9.23 (2.70) 9.45 (2.27)
 Months 3–6 8.37 (1.87) 8.04 (1.78) 7.84 (1.89) 8.21 (1.69)
Trough:TDD Mean (SD), ng/ml mg−1
 Week 3 to Month 6 2.26 (1.38) 1.69 (0.85) 1.90 (0.97) 1.54 (0.73)
 Week 1 1.22 (0.69) 1.09 (0.63) 1.29 (0.69) 0.94 (0.54)
 Week 2 1.46 (0.99) 1.26 (0.91) 1.38 (0.70) 1.18 (1.03)
 Week 3 1.68 (1.14) 1.33 (0.86) 1.58 (1.07) 1.16 (0.62)
 Week 4 1.77 (1.08) 1.44 (0.93) 1.66 (1.13) 1.27 (0.69)
 Months 1–3 2.23 (1.51) 1.68 (0.96) 1.91 (1.09) 1.51 (0.82)
 Months 3–6 2.62 (1.80) 1.87 (0.95) 2.06 (1.05) 1.72 (0.83)

IR-Tac, immediate release tacrolimus; LCPT, LCP tacrolimus; mITT, modified intent-to-treat; PR-Tac, prolonged release tacrolimus; SD, standard deviation; TDD, total daily dose.